CDKN1A, cyclin dependent kinase inhibitor 1A, 1026

N. diseases: 490; N. variants: 17
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0006287
Disease: Bronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
0.010 AlteredExpression disease BEFREE These results suggest that increased CDKN1A expression may be involved in the pathogenesis of BPD through alveolarization and lung retardation. 30755044 2019
CUI: C0020217
Disease: Hydatidiform Mole
Hydatidiform Mole
0.010 Biomarker disease BEFREE The study was performed to investigate the expression patterns of c-erbB-2 and Bcl-2 oncoproteins, p53, p21<sup>WAF1/CIP1</sup> and p63 tumor suppressor proteins and Ki-67 cell proliferation marker in HM. 30558966 2019
CUI: C0029453
Disease: Osteopenia
Osteopenia
0.010 Biomarker disease BEFREE Absence of p21(WAF1/CIP1/SDI1) protects against osteopenia and minimizes bone loss after ovariectomy in a mouse model. 30970032 2019
CUI: C0041234
Disease: Chagas Disease
Chagas Disease
0.010 Biomarker disease BEFREE Fexinidazole Winthrop (hereafter referred to as fexinidazole) is a DNA synthesis inhibitor developed by the Drugs for Neglected Diseases initiative (DNDi), in collaboration with Sanofi, for the oral treatment of human African trypanosomiasis (HAT) [commonly known as 'sleeping sickness'] and Chagas' disease. 30635838 2019
CUI: C0235989
Disease: Renal interstitial fibrosis
Renal interstitial fibrosis
0.010 AlteredExpression disease BEFREE Downregulated expression of XIST led to an increase in miR-93-5p expression, thereby decreasing CDKN1A and suppressing renal interstitial fibrosis in DN. 31545928 2019
CUI: C0238462
Disease: Medullary carcinoma of thyroid
Medullary carcinoma of thyroid
0.010 GeneticVariation disease BEFREE Genetic risk association of CDKN1A and RET gene SNPs with medullary thyroid carcinoma: Results from the largest MTC cohort and meta-analysis. 31408923 2019
CUI: C0346957
Disease: Disseminated Malignant Neoplasm
Disseminated Malignant Neoplasm
0.010 Biomarker phenotype BEFREE This finding suggests that the dysregulation between hsa-let-7a-5p/CDKN1A and hsa-miR-92b-3p/GSTM3 pairs is associated with platinum-based chemoresistance of metastatic cancer cells. 31127646 2019
CUI: C1392786
Disease: Cognitive changes
Cognitive changes
0.010 Biomarker phenotype BEFREE The expression of these proteins in the 2% ethanol group was completely reversed when compared to the 50% ethanol group. p21 <sup>WAF1/CIP1</sup> was involved in the cognitive change induced by ethanol. 31254559 2019
CUI: C1969372
Disease: Tubulointerstitial fibrosis
Tubulointerstitial fibrosis
0.010 AlteredExpression phenotype BEFREE Downregulated expression of XIST led to an increase in miR-93-5p expression, thereby decreasing CDKN1A and suppressing renal interstitial fibrosis in DN. 31545928 2019
Ductal Carcinoma In Situ with Microinvasion
0.010 AlteredExpression disease BEFREE Moreover, simultaneous use of ZnO@Glu-TSC NPs (1/2 MIC) in combination with CIP (1/2 MIC) significantly reduced the expression of <i>norA</i>, <i>norB, norC</i>, and <i>tet38</i> by 5.4-, 3.8-, 2.1-, and 3.4-fold, respectively, compared to the CIP alone. 30855211 2019
CUI: C0023480
Disease: Leukemia, Myelomonocytic, Chronic
Leukemia, Myelomonocytic, Chronic
0.010 Biomarker disease BEFREE Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia. 29797327 2018
Monoclonal Gammopathy of Undetermined Significance
0.010 Biomarker disease BEFREE Protein expression of cyclin-dependent kinase inhibitor p21<sup>Cip1/Waf1</sup> was significantly higher in smoldering multiple myeloma (SMM) compared to monoclonal gammopathy of undetermined significance (MGUS) (p = .02) or symptomatic multiple myeloma (MM) (p = .005). 29616856 2018
CUI: C0030305
Disease: Pancreatitis
Pancreatitis
0.010 Biomarker disease BEFREE Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation. 28774888 2018
CUI: C0206698
Disease: Cholangiocarcinoma
Cholangiocarcinoma
0.010 AlteredExpression disease BEFREE Epigenetic silencing of tumor suppressor gene CDKN1A by oncogenic long non-coding RNA SNHG1 in cholangiocarcinoma. 29970899 2018
CUI: C0220630
Disease: Adult Liver Carcinoma
Adult Liver Carcinoma
0.010 Biomarker disease BEFREE Our observations suggest that miR372 promotes liver cancer cell cycle progress by activating cyclin-dependent kinase 2 (CDK2)-cyclin E-P21/Cip1 complex through miR372-YB-1-β-catenin-LEF/TCF4-PKM2-erbB-2 axis. 29858084 2018
CUI: C0220633
Disease: Uveal melanoma
Uveal melanoma
0.010 Biomarker disease BEFREE CAP (20 μM) induced Ca<sup>2+</sup> transients and increased whole-cell currents in both the UM cell line and PM whereas TRPM8 agonists, 100 μM menthol and 20 μM icilin, blunted such responses in the UM cells. 30483120 2018
Congenital contractural arachnodactyly
0.010 Biomarker disease BEFREE In a mechanistic manner, we also showed that SNHG1 bound to the histone methyltransferase enhancer of the zeste homolog 2 (EZH2, which is regarded as the catalytic subunit of the polycomb repressive complex 2 (PRC2), which is an extremely conserved protein complex regulating gene expression with the help of methylating lysine 27 on histone H3), specifying the histone alteration pattern on the target genes, including CDKN1A, and, as a result, altered the CCA cell biology. 29970899 2018
Liver and Intrahepatic Biliary Tract Carcinoma
0.010 Biomarker disease BEFREE Our observations suggest that miR372 promotes liver cancer cell cycle progress by activating cyclin-dependent kinase 2 (CDK2)-cyclin E-P21/Cip1 complex through miR372-YB-1-β-catenin-LEF/TCF4-PKM2-erbB-2 axis. 29858084 2018
CUI: C1531608
Disease: Smoldering myeloma
Smoldering myeloma
0.010 Biomarker disease BEFREE Protein expression of cyclin-dependent kinase inhibitor p21<sup>Cip1/Waf1</sup> was significantly higher in smoldering multiple myeloma (SMM) compared to monoclonal gammopathy of undetermined significance (MGUS) (p = .02) or symptomatic multiple myeloma (MM) (p = .005). 29616856 2018
CUI: C2609129
Disease: Autoimmune pancreatitis
Autoimmune pancreatitis
0.010 Biomarker disease BEFREE Development of autoimmune pancreatitis is independent of CDKN1A/p21-mediated pancreatic inflammation. 28774888 2018
CUI: C0035369
Disease: Retroviridae Infections
Retroviridae Infections
0.010 Biomarker group BEFREE Transcription and translation of cyclin-dependent kinase inhibitor 1 (p21<sup>Cip1</sup>) and SAM domain and HD domain-containing protein 1 (SAMHD1) were analyzed by TaqMan PCR and Western blot experiments. siRNA experiment was applied to study the role of p53 downstream gene p21<sup>Cip1</sup> in the restriction of retrovirus infection. 28793904 2017
CUI: C0036341
Disease: Schizophrenia
Schizophrenia
0.010 GeneticVariation disease BEFREE The present study aimed to investigate the association of two polymorphisms (rs2844337 and rs11237200) in the P21 protein (cell division control protein 42/Rac)-activated kinase 1 gene with susceptibility to schizophrenia (SCZ) in Chinese Zhuang and Chinese Han populations. 28450949 2017
CUI: C0346156
Disease: Benign neoplasm of breast
Benign neoplasm of breast
0.010 GeneticVariation disease BEFREE None of the malignant and benign breast tumors were found to be hypermethylated at p21^Waf1/Cip1 gene promoter. 28106536 2017
CUI: C0424295
Disease: Hyperactive behavior
Hyperactive behavior
0.010 Biomarker phenotype BEFREE Furthermore, we found that mutp53 proteins hyper-transactivate p53-target gene CDKN1A upon glutamine deprivation, thus triggering cell cycle arrest and promoting cell survival. 27721412 2017
CUI: C1378703
Disease: Renal carcinoma
Renal carcinoma
0.010 AlteredExpression disease BEFREE Kr-POK (ZBTB7c) is a kidney cancer-related POK transcription factor that not only represses transcription of CDKN1A but also increases expression of FASN. 28571744 2017